ACCESSION: MSBNK-SMB_Measured-HSA014P0188001
RECORD_TITLE: Annotated; N-Acetylglutamic acid; LC-ESI-QFT; MS2; NEGATIVE; generated fron DDA dataset
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 22
COMMENT: RAW_SPEC {'EL02-neg_1698': {'bp': 51748.0, 'sum': 334207.0}, 'EL18-neg_1690': {'bp': 46161.0, 'sum': 292001.0}, 'EL06-neg_1690': {'bp': 43402.0, 'sum': 296169.0}, 'EL20-neg_1694': {'bp': 40876.0, 'sum': 304886.0}, 'EL22-neg_1693': {'bp': 38251.0, 'sum': 331331.0}, 'EL03-neg_1692': {'bp': 37205.0, 'sum': 250743.0}, 'EL19-neg_1691': {'bp': 36530.0, 'sum': 276104.0}, 'EL05-neg_1689': {'bp': 36324.0, 'sum': 297193.0}, 'EL23-neg_1691': {'bp': 33982.0, 'sum': 275434.0}, 'EL01-neg_1689': {'bp': 33711.0, 'sum': 247386.0}, 'EL15-neg_1692': {'bp': 33067.0, 'sum': 235952.0}, 'EL08-neg_1684': {'bp': 31638.0, 'sum': 241399.0}, 'EL16-neg_1684': {'bp': 31625.0, 'sum': 227154.0}, 'EL17-neg_1678': {'bp': 31587.0, 'sum': 250480.0}, 'EL14-neg_1686': {'bp': 31557.0, 'sum': 256434.0}, 'EL11-neg_1690': {'bp': 30354.0, 'sum': 241613.0}, 'EL21-neg_1682': {'bp': 30173.0, 'sum': 267177.0}, 'EL09-neg_1687': {'bp': 29892.0, 'sum': 272059.0}, 'EL07-neg_1694': {'bp': 27802.0, 'sum': 252237.0}, 'EL04-neg_1682': {'bp': 27511.0, 'sum': 220414.0}, 'EL24-neg_1680': {'bp': 26435.0, 'sum': 235615.0}, 'EL13-neg_1684': {'bp': 25145.0, 'sum': 240472.0}}
COMMENT: RETENTION_TIME_STDEV 0.006
COMMENT: PRECURSOR_M/Z_RAW 188.055544
COMMENT: PRECURSOR_M/Z_STDEV 0.000092
COMMENT: PRECURSOR_IN_MS1 mz 188.055983; int 26.082; delta(ppm) 1.897087
COMMENT: PROPOSED_CHARGE_STATE -1; mz 189.059514; int 1.999; cor 0.632
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 2.481; C7H11NO5; [M-H]1; delta(ppm) -2.480651
COMMENT: PROPOSED_MF MS-FINDER 3.285; C7H11NO5; [M-H]-; delta(ppm) -2.494126
COMMENT: PROPOSED_MF SIRIUS5_Sirius 15.969; C7H11NO5; [M-H]-; delta(ppm) -2.494126
COMMENT: PROPOSED_MF SIRIUS5_Sirius 3.523; C8H7N5O; [M-H]-; delta(ppm) -9.605826
COMMENT: PROPOSED_MF SIRIUS5_Sirius -1.292; C8H15NS2; [M-H]-; delta(ppm) -7.115139
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C7H11NO5; [M-H]-; delta(ppm) -2.494126
COMMENT: PROPOSED_MF SIRIUS6_Sirius 21.358; C7H11NO5; [M-H]-; delta(ppm) -2.494126
COMMENT: PROPOSED_MF SIRIUS6_Sirius 17.201; C5H9N4O4; [M-H]-; delta(ppm) 4.645592
COMMENT: PROPOSED_MF SIRIUS6_Sirius 15.656; C5H10F3NO3; [M-H]-; delta(ppm) 10.508894
COMMENT: PROPOSED_MF SIRIUS6_Sirius 6.718; C8H7N5O; [M-H]-; delta(ppm) -9.605826
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.421; C6H5N8; [M-H]-; delta(ppm) -2.466211
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.286; C2H8N9P; [M-H]-; delta(ppm) -4.109876
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.292; C8H15NS2; [M-H]-; delta(ppm) -7.115139
COMMENT: PROPOSED_MF SIRIUS6_Sirius -1.643; C8H12FNOS; [M-H]-; delta(ppm) 4.734888
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.534; C8H8F3N2; [M-H]-; delta(ppm) -3.742691
COMMENT: PROPOSED_MF SIRIUS6_Sirius -10.768; C7H14N2PS; [M-H]-; delta(ppm) 9.167410
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.999; C7H11NO5; [M-H]-; delta(ppm) -2.494126
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.001; C5H9N4O4; [M-H]-; delta(ppm) 4.645592
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 15.000; RFMMMVDNIPUKGG-UHFFFAOYSA-N; C7H11NO5; N-Acetyl-L-glutamic acid CollisionEnergy:205060
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 4.000; RFMMMVDNIPUKGG-YFKPBYRVSA-N; C7H11NO5; N-ACETYL-DL-GLUTAMIC ACID
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.635; RFMMMVDNIPUKGG-UHFFFAOYNA-N; [M-H]-; CC(=O)NC(CCC(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.886; OJEOXDLLIADRBL-UHFFFAOYNA-N; [M-H]-; CC1SC2CCCN2C(C)S1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.800; YIBXPFAXPUDDTK-UHFFFAOYSA-N; [M-H]-; CSCCCCCCN=C=S
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.525; NBLKTRLPZFCMJG-UHFFFAOYSA-N; [M-H]-; OC(=O)CCCC(=O)NCC(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.505; WEKGHNWYEFXAQP-SYTVJDICSA-N; [M-H]-; N[C@@H]1C[C@@](O)(CC(=O)[C@H]1O)C(O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.838; RFMMMVDNIPUKGG-UHFFFAOYNA-N; [M-H]-; N-Acetylglutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.317; NBLKTRLPZFCMJG-UHFFFAOYSA-N; [M-H]-; Glutarylglycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.213; UKCSFKLWNHUBDY-BYPYZUCNSA-N; [M-H]-; (S)-2-amino-6-oxopimelic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.160; WEKGHNWYEFXAQP-SYTVJDICSA-N; [M-H]-; AminoDHQ
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.108; PVJADZQYWZQYBF-UHNVWZDZSA-N; [M-H]-; (2S,3R)-2-amino-3-(2-oxopropanoyloxy)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; PVJADZQYWZQYBF-UHNVWZDZSA-N; [M-H]-; (2S,3R)-2-amino-3-(2-oxopropanoyloxy)butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.935; NBLKTRLPZFCMJG-UHFFFAOYSA-N; [M-H]-; Glutarylglycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.917; RFMMMVDNIPUKGG-UHFFFAOYNA-N; [M-H]-; N-Acetylglutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.742; WEKGHNWYEFXAQP-SYTVJDICSA-N; [M-H]-; AminoDHQ
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.487; UKCSFKLWNHUBDY-BYPYZUCNSA-N; [M-H]-; (S)-2-amino-6-oxopimelic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.981; RFMMMVDNIPUKGG-YFKPBYRVSA-N; [M-H]-; (2S)-2-acetamidopentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.378; NBLKTRLPZFCMJG-UHFFFAOYSA-N; [M-H]-; 5-(carboxymethylamino)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.047; WEKGHNWYEFXAQP-SYTVJDICSA-N; [M-H]-; (1R,3R,4S)-3-amino-1,4-dihydroxy-5-oxocyclohexane-1-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.983; QOPCUMZEDYLUDO-UHFFFAOYSA-N; [M-H]-; diethyl 2-hydroxyiminopropanedioate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.919; ZLBJEOOWHZIUMH-UKFBFLRUSA-N; [M-H]-; (3aR,4R,5R,6R,6aS)-4,5-dihydroxy-6-(hydroxymethyl)-3,3a,4,5,6,6a-hexahydrocyclopenta[d][1,3]oxazol-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.786; UKCSFKLWNHUBDY-BYPYZUCNSA-N; [M-H]-; (2S)-2-amino-6-oxoheptanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -7.276; RFMMMVDNIPUKGG; [M-H]-; acetyl-glu
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.835; NBLKTRLPZFCMJG; [M-H]-; Glutarylglycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -179.835; YVIVRLXOTFRIKR; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -193.798; PTARIFVUPQMDHN; [M-H]-; (2S)-2-acetamido-3-acetyloxypropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.987; UKCSFKLWNHUBDY; [M-H]-; 2-Amino-6-ketopimelate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.501; BIYRYXIBPQJLIG; [M-H]-; N-((Vinyloxy)carbonyl)-L-threonine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -237.002; CNEHXYAKIOENGJ; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.236; QOPCUMZEDYLUDO; [M-H]-; Diethyl 2-(hydroxyimino)malonate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -377.341; WEKGHNWYEFXAQP; [M-H]-; AminoDHQ
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -399.640; IZOGBGRDAUVZNB; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.737; RFMMMVDNIPUKGG; [M-H]-; acetyl-glu
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match N-Acetylglutamic acid, RFMMMVDNIPUKGG-YFKPBYRVSA-N; Matching to 4 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0001138;
CH$NAME: N-Acetylglutamic acid
CH$NAME: (2S)-2-acetamidopentanedioic acid
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C7H11NO5
CH$EXACT_MASS: 189.063722
CH$SMILES: CC(=O)N[C@@H](CCC(=O)O)C(=O)O
CH$IUPAC: InChI=1S/C7H11NO5/c1-4(9)8-5(7(12)13)2-3-6(10)11/h5H,2-3H2,1H3,(H,8,9)(H,10,11)(H,12,13)/t5-/m0/s1
CH$LINK: INCHIKEY RFMMMVDNIPUKGG-YFKPBYRVSA-N
CH$LINK: PUBCHEM CID:70914
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.882
MS$FOCUSED_ION: ION_TYPE [M-H]-
MS$FOCUSED_ION: PRECURSOR_M/Z 188.055977
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0ziu-1900000000-ad2f0994fd88276ba32c
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  58.0284123 129.2309 58.028388 1.1374 32.67 0.5018 20 ?
  59.0124895 465.6056 59.012465 1.0845 58.45 0.3829 20 ?
  99.9243959 290.2133 99.924408 0.9107 68.02 -0.1084 20 ?
  100.0753590 195.2314 100.075372 0.9293 37.84 0.4321 17 ?
  102.0546628 999.0000 102.054679 0.4605 30.88 0.5023 22 ?
  114.9058277 97.0598 114.905865 1.7406 33.68 -0.3893 16 ?
  115.9194533 126.9984 115.919492 1.4665 42.25 0.2941 17 ?
  120.0442629 149.4664 120.044310 1.3828 45.45 0.4608 19 ?
  125.0960773 95.4660 125.096135 0.7914 25.99 0.2206 17 ?
  128.0340386 960.4563 128.034102 0.5545 73.62 0.6256 22 f{C5H6N1O3}/-9.98ppm,p-C2H4O2
  132.9165339 572.5045 132.916609 1.0307 175.36 -0.3218 22 ?
  142.8971067 174.9503 142.897206 1.0987 48.22 -0.2000 17 ?
  143.8978324 303.5336 143.897934 0.7088 56.34 0.3627 19 ?
  144.0655873 216.4310 144.065689 1.1106 36.29 0.3602 20 f{C6H10N1O3}/-7.15ppm,p-C1O2
  144.8966288 337.6542 144.896733 1.1318 68.76 0.1323 22 ?
  145.8981044 141.5734 145.898212 1.3708 39.54 -0.1806 20 ?
  158.8921261 185.8929 158.892270 1.6049 45.00 -0.1877 21 ?
  159.8927921 354.9697 159.892939 1.1320 96.57 -0.1807 20 ?
  160.8916050 357.4449 160.891755 1.4855 73.10 0.1113 22 ?
  160.9116061 169.0054 160.911756 1.0005 62.64 -0.5647 18 ?
  161.8931042 155.1284 161.893257 1.1551 43.40 0.0613 18 ?
  188.0557374 193.3437 188.055655 1.0848 41.44 1.0000 20 f{C7H10N1O5}/-3.77ppm,p
PK$NUM_PEAK: 22
PK$PEAK: m/z int. rel.int.
  58.028412 129.23 129
  59.012489 465.61 465
  99.924396 290.21 290
  100.075359 195.23 195
  102.054663 999.00 999
  114.905828 97.06 97
  115.919453 127.00 126
  120.044263 149.47 149
  125.096077 95.47 95
  128.034039 960.46 960
  132.916534 572.50 572
  142.897107 174.95 174
  143.897832 303.53 303
  144.065587 216.43 216
  144.896629 337.65 337
  145.898104 141.57 141
  158.892126 185.89 185
  159.892792 354.97 354
  160.891605 357.44 357
  160.911606 169.01 169
  161.893104 155.13 155
  188.055737 193.34 193
//
